Bancel Takes Commercial Reins As Moderna Braces For 2024 Downturn

Moderna is saying goodbye to its second chief commercial officer in three years and CEO Stéphane Bancel will direct operations personally – including the firm’s anticipated RSV vaccine launch in 2024